JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Clinical Pathology 2008;61:588-594; doi:10.1136/jcp.2007.049775
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kidambi, S
Right arrow Articles by Patel, S B
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kidambi, S
Right arrow Articles by Patel, S B
Right arrowPubmed/NCBI databases
*Substance via MeSH

REVIEWS

Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis

S Kidambi1, S B Patel1,2

1 Division of Endocrinology (Department of Medicine), Medical College of Wisconsin, Milwaukee, Wisconsin, USA
2 Department of Veterans Affairs, Clement J. Zablockiva VA Medical Center, Milwaukee, Wisconsin, USA

Correspondence to:
Dr S Kidambi, Division of Endocrinology (Department of Medicine), 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA; skidambi{at}mcw.edu; sbpatel{at}mcw.edu

Sitosterolaemia is an extremely rare autosomal recessive disease, the key feature of which is the impairment of pathways that normally prevent absorption and retention of non-cholesterol sterols, for example plant sterols and shellfish sterols. The clinical manifestations are akin to familial hypercholesterolaemia (such as presence of tendon xanthomas and premature atherosclerosis), but with "normal to moderately elevated" cholesterol levels. The gene(s) causing sitosterolaemia was mapped to the STSL locus on human chromosome 2p21, and mutations in either of the two genes that comprise this locus, ABCG5 or ABCG8, cause this disease. Exact prevalence is unknown, but there are estimated to be 80–100 cases around the world. This rare disease has shed light into the molecular mechanisms that control sterol trafficking in the enterocyte and hepatocyte; ABCG5 and ABCG8 heterodimerise to form a sterol efflux transporter in the liver and intestine. In this review the pathophysiology, clinical manifestations and approach to clinical and laboratory diagnosis of this disease are described.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.